DiabetesSeriesLive

CME Speakers

Long-acting Insulins

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist and Diabetes Educator

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director, Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism and Molecular Medicine

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.

Evolution of Insulin Replacement Therapy

Current Advances in Insulin Therapy: Improving Skills for Clinical Care

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist and Diabetes Educator

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director, Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism and Molecular Medicine

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.

All Speakers

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist and Diabetes Educator

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director, Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism and Molecular Medicine

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Samuel E. Crockett Chair in Diabetes Research; Director

    Richard E. Pratley, MD, is medical director of education and research at the Florida Hospital Diabetes Institute, senior investigator and diabetes program lead at the Translational Research Institute for Metabolism and Diabetes, and adjunct professor at the Sanford-Burnham Prebys Medical Discovery Institute in Orlando. His research interests include diabetes prevention, improving the care for older persons with diabetes, new drug development to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He is a member of numerous professional organizations, and is as an editorial board member and/or ad hoc reviewer for various journals. He received his MD from Wayne State University in Detroit, Michigan.
  • Anne L. Peters, MD

    Anne L. Peters, MD

    Anne L. Peters, MD

    Director, Clinical Diabetes Program; Professor, Keck School of Medicine

    Anne L. Peters, MD, is a professor of clinical medicine at the Keck School of Medicine of the University of Southern California in Los Angeles and the director of the USC Clinical Diabetes Program. Her interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She is currently the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Dr Peters has published over 200 articles, reviews and abstracts, and 3 books on diabetes, and has been an investigator on over 40 research studies. She earned her medical degree from the Pritzker School of Medicine at the University of Chicago in Illinois.
  • Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Assistant Professor of Medicine, Division of Endocrinology

    Jeremy H. Pettus, MD, is an assistant professor of medicine in the Division of Endocrinology at the University of California, San Diego (UCSD). After being diagnosed with type 1 diabetes himself at the age of 15, Dr Pettus has dedicated his career toward treating and educating others with the disease. He now specializes in type 1 diabetes-related clinical research with studies involving immunotherapeutics, islet cell encapsulation, and adjunctive therapies beyond insulin. He also has a background in basic immunology research with a focus on biomarkers for type 1 diabetes disease activity. In addition to his clinical duties, he is a speaker for the not-for-profit organization, Taking Control of Your Diabetes (TCOYD). He earned his medical degree from Boston University School of Medicine.
  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.